Hi Elmat,
Viral drug targets are not all the same,,, and viral mechanisms tend to vary. This is the real value of drug libraries,,, and we are lucky to live in this day and age, when the value of the science means we will not have to wait like, HIV, or even SARS etc.
Production ramp up-- on other hand is not instant, and supplies of drugs, especially in current day and age of on-demand manufacture and inventory by order. So inside players here have a hefty advantage. Even among India, and China supply chain still need raw materials, still need know how etc. If no such experience,,,, at least 6 months even at breakneck speed. If using a recipe,,, still 6-months to 10X + multiple of production. So if contained-- surely we are good,,, if not contained,,, perhaps 6 -16 months for full scale worldwide production depending on supply chain.
Big Pharma, PFE, Roche, BMS, Sanofi, etc... have all run away from infections disease,,,despite biotech's insistence on other,,, it is simply not,,, simple. nytimes.com (yes, antibiotics are not antiviral... but you can get the gist,,, as coronavirus maybe you have for a month). Consider even Hep C,,, and why screaming over $73,000 to treat disease,,, when before drug,,, treatment was $100K. Simply put,,, this is an area that not many can afford to play,,, and those that can are rewarded handsomely. So even if,,,, IP theft, or world giveaway,,, won't change global stockpiling for a rainy day.,,, and said rainy day is here,,, even if,,, some think is waste-o-money.
reuters.com |
